Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Charalampos, Papagoras"'
Autor:
Dimitrios T Boumpas, Antonis Fanouriakis, Prodromos Sidiropoulos, George Bertsias, Maria G Tektonidou, Petros P Sfikakis, Antigone Pieta, Dimitrios Vassilopoulos, Maria Pappa, Paraskevi V Voulgari, Myrto Nikoloudaki, Theodoros Dimitroulas, Andreas Goules, Charalampos Papagoras, Christina Tsalapaki, Kyriaki A Boki, Harikleia Gakiopoulou, Maria Kosmetatou, Evangelia Argyriou, Aglaia Chalkia, Georgios Demirtzoglou, Christina Katsiari, Nektarios Marios Liapis, Myrto Cheila, George Liapis
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objective To estimate real-life European Alliance of Associations for Rheumatology (EULAR)/European Renal Association (ERA)-European Dialysis and Transplantation Association (EDTA) response rates and predictors for no response in patients with lupus
Externí odkaz:
https://doaj.org/article/6bff2348355b47cc985fb0344eeeafb4
Autor:
Maria Tektonidou, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis, Prodromos Sidiropoulos, Petros P Sfikakis, Antigone Pieta, Dimitrios Vassilopoulos, Maria Pappa, Paraskevi V Voulgari, Theodoros Dimitroulas, Andreas Goules, Charalampos Papagoras, Christina Tsalapaki, Maria Kosmetatou, Flora Chouzouri, Evangelia Argyriou, Aglaia Chalkia, Mirto Cheila, Georgios Demirtzoglou, Christina Katsiari, Dimitrios Petras, Kyriaki Boki
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/692ef3146c6444f8991a42f0240eb682
Autor:
Charalampos Papagoras, Styliani Tsiami, Akrivi Chrysanthopoulou, Ioannis Mitroulis, Xenofon Baraliakos
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-5 (2022)
Abstract Background Accumulating evidence supports the role of monocytes and neutrophils in radiographic axSpA (r-axSpA). Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a growth factor for both leukocyte lineages and a pro-inflammatory
Externí odkaz:
https://doaj.org/article/7a6ff68229fa4483b49d6e1d79850444
Autor:
Aysel Mehmet, Eirini-Kanella Panagiotopoulou, Aristeidis Konstantinidis, Charalampos Papagoras, Panagiotis Skendros, Doukas Dardabounis, Athanasia Maria Mikropoulou, Georgios Labiris
Publikováno v:
Acta Medica, Vol 64, Iss 1, Pp 64-69 (2021)
This is a case report describing a patient with severe thyroid eye disease complicated with dysthyroid optic neuropathy that was unresponsive to intravenous steroids and orbital radiotherapy but responded well to intravenous tocilizumab.
Externí odkaz:
https://doaj.org/article/0ae30cc73a0641b9955e593b7656412d
Autor:
Petros P. Sfikakis, Dimitrios Vassilopoulos, Gkikas Katsifis, Georgios Vosvotekas, Theodoros Dimitroulas, Prodromos Sidiropoulos, Periklis Vounotrypidis, Dimitrios P. Bogdanos, Athanasios Ι. Georgountzos, Andreas G. Bounas, Panagiotis Georgiou, Souzana Gazi, Evangelia Kataxaki, Stamatis-Nick Liossis, Evangelos Theodorou, Charalampos Papagoras, Evangelos Theotikos, Panayiotis Vlachoyiannopoulos, Paraskevi V. Voulgari, Angeliki Kekki, Nikolaos Antonakopoulos, Dimitrios T. Boumpas
Publikováno v:
Rheumatology International. 43:889-902
To evaluate the effect of the phosphodiesterase 4 inhibitor apremilast in biologic-naïve patients with early peripheral PsA in terms of disease activity, clinical manifestations, patient-perceived outcomes, as well as apremilast’s safety profile i
Publikováno v:
Rheumatology.
Autor:
Charalampos Papagoras, Stella Arelaki, Ioannis Botis, Ioannis Chrysafis, Stavros Giannopoulos, Panagiotis Skendros
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
We present a case of dermatomyositis together with polycythemia as initial manifestations of a particularly rare type of prostate cancer. A 69-year-old man was hospitalized for facial erythema and symptoms of fatigue. Physical evaluation, serum creat
Externí odkaz:
https://doaj.org/article/48908d3d23f4413a84cd9efebae11039
Autor:
Anja Strangfeld, Ana M. Rodrigues, Loreto Carmona, Ludovic Trefond, Charalampos Papagoras, Laure Gossec, N Roux, Kimme L. Hyrich, Saskia Lawson-Tovey, Bernd Raffeiner, Elsa F Mateus, Gözde Kübra Yardımcı, Pedro Machado, Xavier Mariette
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Lawson-Tovey, S, Hyrich, K L, Gossec, L, Strangfeld, A, Carmona, L, Raffeiner, B, Yardımcı, G K, Trefond, L, Roux, N, Rodrigues, A, Papagoras, C, Mateus, E F, Mariette, X & Machado, P M 2021, ' SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases ', Annals of the rheumatic diseases . https://doi.org/10.1136/annrheumdis-2021-221217
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Annals of the Rheumatic Diseases, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Lawson-Tovey, S, Hyrich, K L, Gossec, L, Strangfeld, A, Carmona, L, Raffeiner, B, Yardımcı, G K, Trefond, L, Roux, N, Rodrigues, A, Papagoras, C, Mateus, E F, Mariette, X & Machado, P M 2021, ' SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases ', Annals of the rheumatic diseases . https://doi.org/10.1136/annrheumdis-2021-221217
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2022, 81 (1), pp.145-150. ⟨10.1136/annrheumdis-2021-221217⟩
Patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) are often treated with immunomodulatory or immunosuppressive medications; consequently, they have been excluded alongside other immunocompromised patients from late stages of S
Autor:
Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, Christina Antoniadou, Efstratios Gavriilidis, Georgios Kalopitas, Anna Samakidou, Angelos Liontos, Akrivi Chrysanthopoulou, Maria Ntinopoulou, Dionysios Kogias, Ioanna Karanika, Andreas Smyrlis, Dainora Cepaityte, Iliana Fotiadou, Nikoleta Zioga, Ioannis Mitroulis, Nikolaos K. Gatselis, Charalampos Papagoras, Simeon Metallidis, Haralampos Milionis, George N. Dalekos, Loek Willems, Barbro Persson, Vivek Anand Manivel, Bo Nilsson, E. Sander Connolly, Simona Iacobelli, Vasileios Papadopoulos, Rodrigo T. Calado, Markus Huber-Lang, Antonio M. Risitano, Despina Yancopoulou, Konstantinos Ritis, John D. Lambris
Publikováno v:
Science Advances. 8
Complement C3 activation contributes to COVID-19 pathology, and C3 targeting has emerged as a promising therapeutic strategy. We provide interim data from ITHACA, the first randomized trial evaluating a C3 inhibitor, AMY-101, in severe COVID-19 (PaO2
Autor:
Charalampos Papagoras, Georgios Labiris, Aysel Mehmet, Aristeidis Konstantinidis, Athanasia Maria Mikropoulou, Panagiotis Skendros, Eirini Kanella Panagiotopoulou, Doukas Dardabounis
Publikováno v:
Acta Medica, Vol 64, Iss 1, Pp 64-69 (2021)
This is a case report describing a patient with severe thyroid eye disease complicated with dysthyroid optic neuropathy that was unresponsive to intravenous steroids and orbital radiotherapy but responded well to intravenous tocilizumab.